Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Genome-wide Association Studies-GWAS

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

Ribosome Profiling

Ribosome Profiling

Ribosome profiling or ribo-sequencing is a deep sequencing technique that produces a snapshot of active translation in a cell. It selectively sequences the mRNAs protected by ribosomes to get an insight into a cell’s translation landscape at any given point in time.
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique helps...

The JAK-STAT Signaling Pathway

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Autoantibody Specificities and Type I Interferon Pathway Activation in Idiopathic Inflammatory Myopathies.

Scandinavian journal of immunology·2016

Same author

Gene expression analysis in RA: towards personalized medicine.

The pharmacogenomics journal·2014

Same author

Gene-expression signatures: biomarkers toward diagnosing multiple sclerosis.

Genes and immunity·2011

Same author

Biomarkers and personalised medicine in rheumatoid arthritis: a proposal for interactions between academia, industry and regulatory bodies.

Annals of the rheumatic diseases·2011

Same author

Interferon regulatory factor 5 gene variants and pharmacological and clinical outcome of Interferonβ therapy in multiple sclerosis.

Genes and immunity·2011

Same author

Pharmacogenomics of infliximab treatment using peripheral blood cells of patients with rheumatoid arthritis.

Genes and immunity·2010

Search research articles

Related Experiment Videos

Transcript profiling towards personalised medicine in rheumatoid arthritis.

¹Department of Pathology and Rheumatology, VU University Medical Center, Amsterdam, the Netherlands. c.verweij@vumc.nl

The Netherlands Journal of Medicine

|December 17, 2009

Summary

Genomics research, including DNA microarrays, offers insights into rheumatoid arthritis (RA) complexity. This approach aids in identifying biomarkers for personalized medicine and understanding RA pathogenesis.

Related Experiment Videos

Area of Science:

Genomics and Molecular Biology
Immunology and Rheumatology

Background:

Rheumatoid arthritis (RA) is a complex, heterogeneous inflammatory joint disease with variable treatment responses.
Current understanding of RA's molecular complexity is limited, often treating it as a group average.

Purpose of the Study:

To explore how genomics research, particularly DNA microarray technology, can elucidate the complexity of RA.
To identify potential biomarkers for early diagnosis, prognosis, and patient stratification in RA.
To establish a framework for a personalized medicine approach to RA treatment.

Main Methods:

Utilizing DNA microarray technology for comprehensive gene and biological pathway surveying.
Analyzing molecular data to associate genetic findings with clinically defined RA conditions.

Main Results:

Genomics research provides a powerful framework for understanding RA pathogenesis.
Encouraging results have been generated in the molecular description of complex diseases over the last decade.
Potential for identifying biomarkers for diagnosis, prognosis, and stratification.

Conclusions:

Genomics advancements are crucial for unraveling RA's heterogeneity.
This research paves the way for personalized medicine strategies in managing rheumatoid arthritis.
Biomarker discovery through genomics can significantly improve RA patient care and outcomes.